Doctor Strange, Sorcerer Supreme#3(1989)

Capital Math Ground Truth: $88.00 all-in slabbing hurdle + $4.67 raw acquisition stacks the breakeven cost basis at $92.67. Anything cleared above $92.67 is an operational win; anything under is a capital loss. At current 9.8 market pricing of $113.79, successful CPR yield generates +$21.12 (+23%) in positive capital expansion above cost basis. Furthermore, falling to a 9.6 drops to ~$39.83 (an immediate ~$52.84 / ~57% loss on capital spent). PRE-SCREEN PROTOCOL: Savvy traders deploy a $9.00 Pre-Screen threshold (+$9.00 pro-rated freight = $18.00 total reject exposure) to pre-screen raw books prior to final slabbing. If the initial grader inspection determines the book falls below 9.8 (e.g. 9.6), the book is returned unslabbed, saving $40+ in wasted encapsulation costs and protecting portfolio cash. This high-stakes grading asymmetry is why the asset commands a disciplined accumulate (buy with caution) rating.

The secondary market mathematically supports this hurdle: recent sales cleared at $113.79 (yielding +$21.12 net profit over capital floor), while peak historical auction comps reached $130.86. Realized high-water comps prove that smart accumulation capital willingly pays the premium when verified pristine copies emerge from a tight 50-copy census.

Macro tailwinds—including cinematic adaptation cycles for Silver Surfer, generational collector reverence, and tight 50-slab registered census float—support sustained institutional demand over a 3-year investment horizon.